Tai Kwong, Ph.D.Professor of Pathology and Laboratory Medicine Substance Abuse Testing, Therapeutic Drug Monitoring URMC Labs Director of the Regional Toxicology Laboratory, and of the Automated Laboratories. His areas of interest and responsibility include clinical toxicology, therapeutic drug monitoring, substance abuse testing, forensic urine drug texting, and endocrine and immunoassay testing. QualificationsPh.D., Biochemistry, University of Toronto 1973 Research OverviewDr. Kwong's research activities have also focused on toxicology and drug analysis. Recent projects have included assessments of test utility, the development of new methods and uses for toxologic tests, and participation in therapeutic drug clinical trials. PublicationsWu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National Academy of Clinical Biochemistry Laboratory Medicine. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003 Mar;49(3):357-79. Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit. 2002 Feb;24(1):144-9. Scheidweiler KB, Shojaie J, Plessinger MA, Wood RW, Kwong TC. Stability of methylecgonidine and ecgonidine in sheep plasma in vitro. Clin Chem. 2000 Nov;46(11):1787-95. Shearer DS, Baciewicz GJ, Kwong TC. Drugs of abuse testing in a psychiatric outpatient service. Clin Lab Med. 1998 Dec;18(4):713-26. Review. Kwong TC, Shearer D. Detection of drug use during pregnancy. Obstet Gynecol Clin North Am. 1998 Mar;25(1):43-64. Review. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn drug testing. National Academy of Clinical Biochemistry. Clin Chem. 1997 Jan;43(1):235-42. Review. |


